Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
20 sept. 2018 07h37 HE
|
Precipio, Inc.
New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO), announced...
Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
15 févr. 2018 08h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO) announced today its launch of the first lung cancer treatment resistance panel specifically for the critical...